PSTX

Poseida Therapeutics, Inc. Common Stock
PSTX

Overview Fund Activity
Delisted

PSTX was delisted on the 7th of January, 2025.

Back to rankings

86 hedge funds and large institutions have $108M invested in Poseida Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
86
Holders Change
-8
Holders Change %
-8.51%
% of All Funds
1.37%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
11
Increased
29
Reduced
23
Closed
19
Calls
$235K
Puts
$39K
Net Calls
+$196K
Net Calls Change
+$41K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$6.08M
2
SCM
2
Silverarc Capital Management
Massachusetts
$8.49M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$1.86M
4
Connor, Clark & Lunn Investment Management (CC&L)
4
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$816K
5
Goldman Sachs
5
Goldman Sachs
New York
$1.11M

Top Sellers

1
EC
1
EcoR1 Capital
California
$0
2
Two Sigma Investments
2
Two Sigma Investments
New York
$0
3
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$920K
4
Morgan Stanley
4
Morgan Stanley
New York
$664K
5
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$2.03M
Name Holding Trade Value Shares
Change 		Shares
Change %
SFI
101
Susquehanna Fundamental Investments
Pennsylvania
– -$18.4K -10,447 Closed
GCM
102
Gladius Capital Management
Illinois
– -$16.1K -9,125 Closed
QC
103
Quent Capital
New York
– -$3.52K -2,000 Closed
IPW
104
Impact Partnership Wealth
Georgia
– -$475 -270 Closed
1 2 3 4
5